FGF-2: Phase II

CHIR said that in a double-blind, placebo-controlled Phase II trial of its FGF-2 to treat PAD in 190

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE